<--- Back to Details
First PageDocument Content
Blood / Coagulation system / Autoimmune diseases / Lupus anticoagulant / Antiphospholipid syndrome / Partial thromboplastin time / Mixing study / Prothrombin time / Clinical and Laboratory Standards Institute / Blood tests / Anatomy / Medicine
Blood
Coagulation system
Autoimmune diseases
Lupus anticoagulant
Antiphospholipid syndrome
Partial thromboplastin time
Mixing study
Prothrombin time
Clinical and Laboratory Standards Institute
Blood tests
Anatomy
Medicine

Add to Reading List

Source URL: shopping.netsuite.com

Download Document from Source Website

File Size: 1,68 MB

Share Document on Facebook

Similar Documents

Blood tests / Coagulation system / Thrombin time / Thromboplastin / Coagulation testing / Fibrinogen / Prothrombin time / Partial thromboplastin time / Coagulation / Thrombin / Venipuncture / Anticoagulant

Veterinärmedizinisches Labor Universität Zürich Winterthurerstrasse 260 CH-8057 Zürich Telefon +Telefax +

DocID: 1powD - View Document

Anatomy / Blood tests / Coagulation / Prothrombin time / Thromboplastin / Fibrinogen / Thrombin / Antithrombin / Partial thromboplastin time / Blood / Coagulation system / Hematology

Routine Coagulation Reagents Activated Partial Thromboplastin Time (aPTT) Antithrombin III (ATIII) Prothrombin Time (PT) Thrombin Time (TT) Fibrinogen

DocID: 1aOgJ - View Document

Blood / Low molecular weight heparin / Factor X / Coagulation / Anticoagulant / Partial thromboplastin time / Heparins / Hematology / Coagulation system

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of M118, a Novel Rationally Engineered Low Molecular Weight Heparin Given as a Subcutaneous Injection in a Rising Dose Cohort Regimen in Healthy Subjects S. Bou

DocID: 19tt1 - View Document

Heparins / Anatomy / Low molecular weight heparin / Factor X / Coagulation / UFH / Antithrombin / Partial thromboplastin time / Anticoagulant / Blood / Coagulation system / Hematology

Efficacy of M118, a Rationally-Engineered Low-Molecular-Weight Heparin, in a Canine Model of Arterial Thrombosis Ian D Fier1, Mark A Nedelman1, J Luis Guerrero2, Ganesh Venkataraman1, and Yi Wei Qi1 Momenta Pharmaceutica

DocID: 19s56 - View Document

Low molecular weight heparin / Factor X / Coagulation / Protamine sulfate / Partial thromboplastin time / Vitamin A / Biology / Heparins / Coagulation system / Medicine

Figure 2: Mean ACT with Increasing Dose of M118

DocID: 19obY - View Document